Frank V Fossella Selected Research

Frank V Fossella Research Topics

Disease

43	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2023 - 02/2001
23	Neoplasms (Cancer) 08/2023 - 04/2002
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2014 - 06/2003
6	Neutropenia 05/2023 - 04/2002
5	Fever (Fevers) 05/2023 - 05/2004
5	Lung Neoplasms (Lung Cancer) 01/2023 - 04/2005
4	Infections 05/2023 - 07/2002
4	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2005
4	Diarrhea 10/2019 - 04/2002
3	Pneumonia (Pneumonitis) 08/2023 - 01/2018
3	Febrile Neutropenia 05/2023 - 07/2002
3	Exanthema (Rash) 02/2018 - 04/2002
3	Disease Progression 05/2010 - 12/2002
3	Vomiting 06/2007 - 04/2002
3	Nausea 06/2007 - 04/2002
2	Alopecia (Baldness) 05/2023 - 05/2004
2	Sepsis (Septicemia) 01/2022 - 02/2018
2	Agranulocytosis (Granulocytopenia) 02/2018 - 07/2002
2	Esophagitis 01/2009 - 06/2003
2	Thrombocytopenia (Thrombopenia) 06/2007 - 04/2002
2	Asthenia 12/2005 - 04/2002
2	Mucositis 12/2005 - 04/2002
2	Carcinoma (Carcinomatosis) 08/2005 - 07/2002
2	Mesothelioma 07/2004 - 04/2002
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Pathologic Complete Response 01/2021
1	Hypertension (High Blood Pressure) 10/2019
1	Dehydration (Water Stress) 10/2019
1	Weight Loss (Weight Reduction) 10/2019
1	Malignant Mesothelioma 10/2019
1	Hypokalemia 02/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2018
1	Mediastinal Diseases 01/2018
1	Hypoxia (Hypoxemia) 12/2013
1	Squamous Cell Carcinoma of Head and Neck 12/2011

Drug/Important Bio-Agent (IBA)

12	Docetaxel (Taxotere)FDA Link 05/2023 - 02/2001
11	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 02/2001
7	Pemetrexed (MTA)FDA Link 05/2023 - 04/2002
6	Paclitaxel (Taxol)FDA LinkGeneric 05/2010 - 11/2002
6	Gemcitabine FDA Link 04/2010 - 07/2002
5	Carboplatin (JM8)FDA LinkGeneric 05/2010 - 10/2004
4	Biomarkers (Surrogate Marker)IBA 10/2016 - 12/2011
4	Etoposide (VP 16)FDA LinkGeneric 05/2010 - 06/2003
3	NivolumabIBA 01/2023 - 01/2021
3	Angiogenesis InhibitorsIBA 10/2019 - 11/2002
3	PlatinumIBA 02/2018 - 06/2002
3	Taxoids (Taxanes)IBA 12/2011 - 02/2004
3	Irinotecan (Camptosar)FDA LinkGeneric 05/2010 - 07/2003
3	Vinorelbine (Navelbine)FDA LinkGeneric 04/2010 - 07/2002
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2023 - 05/2004
2	IpilimumabIBA 01/2023 - 01/2021
2	HM781-36BIBA 11/2022 - 01/2022
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2018 - 10/2016
2	Sorafenib (BAY 43-9006)FDA Link 10/2016 - 12/2013
2	Imatinib Mesylate (Gleevec)FDA Link 12/2011 - 02/2004
2	lonafarnib (SCH 66336)IBA 08/2005 - 05/2004
2	taxaneIBA 08/2005 - 05/2004
2	Farnesyltranstransferase (Farnesyltransferase)IBA 08/2005 - 05/2004
2	MutagensIBA 04/2005 - 04/2005
2	Bleomycin (Blenoxane)FDA LinkGeneric 04/2005 - 04/2005
2	Amifostine (Ethyol)FDA LinkGeneric 04/2005 - 04/2004
2	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 10/2004 - 11/2002
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 08/2023
1	osimertinibIBA 08/2023
1	capmatinibIBA 08/2023
1	tepotinibIBA 08/2023
1	CrizotinibIBA 08/2023
1	pembrolizumabIBA 01/2023
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	selinexorIBA 01/2023
1	trametinibIBA 01/2022
1	nintedanibIBA 01/2020
1	cediranib (AZD2171)IBA 10/2019
1	CobaltIBA 01/2018
1	VaccinesIBA 10/2017
1	Immune Checkpoint InhibitorsIBA 10/2017
1	AZD 6244IBA 10/2016
1	MK 2206IBA 10/2016
1	lorvotuzumab mertansineIBA 01/2016
1	Maytansine (Maitansine)IBA 01/2016
1	Immunoconjugates (Immunoconjugate)IBA 01/2016
1	Fibroblast Growth Factor 1 (FGF-1)IBA 12/2013
1	Tyrosine Kinase InhibitorsIBA 12/2011
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2011
1	Bevacizumab (Avastin)FDA Link 05/2010
1	Filgrastim (Neupogen)FDA Link 04/2010

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 05/2023 - 02/2001
18	Therapeutics 08/2023 - 12/2002
9	Radiotherapy 01/2023 - 04/2002
5	Chemoradiotherapy 01/2023 - 01/2004
3	Immunotherapy 01/2023 - 07/2016
3	Proton Therapy 01/2021 - 01/2018
2	Induction Chemotherapy 06/2004 - 01/2004
1	Neoadjuvant Therapy 01/2023
1	Perioperative Period 02/2018
1	Aftercare (After-Treatment) 01/2018
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2012
1	Combination Drug Therapy (Combination Chemotherapy) 04/2010
1	Salvage Therapy 04/2010